Eunsol Seo

Eunsol Seo

Auto-generated profile, based on publicly available information

Eunsol Seo

Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Science, Seoul National University, Seoul, 08826, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2025 in Current Research in Food Science
Verified
Journal Article
Open access
AKAnna Kang
Anna Kang
JEJu Young Eor
Ju Young Eor
JLJunbeom Lee
Junbeom Lee
MKMin-Jin Kwak
Min-Jin Kwak
DLDaniel Junpyo Lee
Daniel Junpyo Lee
YKYounghoon Kim
Younghoon Kim
Lacticaseibacillus casei IDCC 3451 (3451) was evaluated for its effects on the gut-brain axis using Caenorhabditis elegans (C. elegans) and mouse models of stress and inflammation. In C. elegans, 3451 extended lifespans by 25 %, improved motility, and chemotaxis, enhanced survival under pathogen challenge, and reduced amyloid beta accumulation by 42 %. Transcriptomic profiling revealed upregulation of genes involved in neurotransmitter signaling and serine/threonine pathways. In the unpredictable chronic mild stress (UCMS) mouse model, 3451 administration increased the time spent in the center of the open field by 65 % and reduced immobility in the forced swim test by 32 %, indicating anxiolytic and antidepressant effects. Serum levels of aspartate aminotransferase (AST) and gamma-glutamyl transferase (GGT) were decreased by 18 % and 24 %, respectively. Additionally, 3451 restored the expressions of 5HT1AR, GABAR, and tight junction proteins, including ZO-1 and Claudin1. Metabolomic analysis showed increased glycine and decreased palmitic acid levels, associated with an increased abundance of Ruminococcus and Akkermansia. In the dextran sulfate sodium (DSS)-induced colitis model, 3451 reduced the disease activity index by 36 %, improved colon histology, increased goblet cell preservation, and upregulated ZO-1 and IL-10 expression. Threonine levels were also increased and correlated with a higher abundance of Coprococcus. These findings demonstrate that 3451 improved behavioral and intestinal outcomes through coordinated modulation of host signaling, metabolite production, and gut microbial composition, highlighting its therapeutic potential for managing IBD and neurobehavioral disorders.

11 June 2025 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
AKAnna Kang
Anna Kang
HCHye Jin Choi
Hye Jin Choi
WLWoong Ji Lee
Woong Ji Lee
MKMin-Geun Kang
Min-Geun Kang
ESEunsol Seo
Eunsol Seo
YKYounghoon Kim
Younghoon Kim

29 August 2025 in Current Research in Food Science
Verified
Journal Article
Open access
SLSe Hyun Lim
Se Hyun Lim
DMDaye Mun
Daye Mun
SRSangdon Ryu
Sangdon Ryu
MKMin-Geun Kang
Min-Geun Kang
AKAnna Kang
Anna Kang
YKYounghoon Kim
Younghoon Kim
Milk kefir is a fermented dairy product composed of a complex consortium of microorganisms, including lactic acid bacteria (LAB), yeasts, and acetic acid bacteria. Despite growing interest in its health-promoting properties, the synergistic interactions among the diverse microbial constituents of kefir remain insufficiently characterized. This study investigated the probiotic potential of milk kefir through a multi-omics approach. Two strains, Kluyveromyces marxianus SLAM 005Y and Lentilactobacillus kefiri SLAM 023B, were isolated from Korean household milk kefir. Both strains exhibited key probiotic properties, including antibacterial activity, adherence to intestinal epithelial cells, and resistance in simulated gastrointestinal conditions. Supplementation with SLAM 005Y, SLAM 023B, or their synergistic combination (SYN) significantly enhanced lifespan and immune function in Caenorhabditis elegans. Transcriptomic analysis further revealed upregulation of genes involved in longevity and antimicrobial defense, suggesting the activation of conserved stress-response pathways. In a dextran sulfate sodium (DSS)-induced murine colitis model, SYN administration led to marked improvement in clinical outcomes. SYN also restored the expression of inflammatory and anti-inflammatory cytokines and tight junction proteins, indicating improved intestinal barrier function and immune regulation. Importantly, multi-omics analysis revealed that SYN altered both gut microbial composition and fecal metabolite profiles, supporting a mechanistic link between microbiota modulation and host health. Taken together, milk kefir strains SLAM 005Y and SLAM 023B, particularly in combination, exhibit strong probiotic properties. Our findings highlight the therapeutic potential of milk kefir-originated probiotics as a functional food for improving intestinal health.

18 June 2026 in Journal of Translational Medicine
Verified
Journal Article
Open access
ESEunsol Seo
Eunsol Seo
SKSeung Hyun Kim
Seung Hyun Kim
MKMin-Jin Kwak
Min-Jin Kwak
JHJae Kyoon Hwang
Jae Kyoon Hwang
GMGhulam Mustafa
Ghulam Mustafa
YKYounghoon Kim
Younghoon Kim
Neonatal respiratory distress syndrome (RDS) is among the most prevalent morbidities in late preterm and term infants. Although the gut-lung axis has been implicated in neonatal respiratory disease, the relationship between RDS and early gut microbiome composition remains poorly characterized. This study aimed to characterize gut microbiome alterations associated with RDS and surfactant replacement therapy (SRT), and to evaluate the biological plausibility of a disease-specific probiotic intervention. Two complementary cohorts were prospectively enrolled. In the clinical observational cohort (n = 45), fecal samples collected within 48 h of birth were analyzed by Nanopore 16S rRNA sequencing across three groups: infants without RDS (control group, n = 25), infants with RDS who did not receive SRT (RDS(S-) group, n = 7), and infants with RDS who received SRT (RDS(S+) group, n = 13). In the probiotic discovery cohort (n = 40), gut microbiota of infants without RDS (CON group, n = 17) and infants with RDS (RDS group, n = 23) were characterized by metagenomic sequencing and culturomics. Candidate probiotic strains were evaluated in a fermenter for intestinal microbiota model (FIMM) and a fecal microbiota transplantation (FMT) mouse model. The RDS(S-) group exhibited depletion of beneficial taxa including Bifidobacterium and Lacticaseibacillus and enrichment of opportunistic pathogens including Enterococcus and Staphylococcus. Following SRT, gut microbial profiles partially shifted toward those of the control group. Limosilactobacillus fermentum SLAM_LAF05 and Bifidobacterium longum SLAM_BIL02 were identified as CON-enriched candidate probiotic strains through direct microbiome comparison and selected based on superior acid and bile tolerance and adhesion capacity. In the FIMM model, probiotic supplementation increased microbial diversity and suppressed opportunistic pathogens. In the FMT mouse model, probiotic supplementation was associated with upregulation of ZO-1, MUC2, and Reg3g, reduction of fecal calprotectin, and restoration of serum IgG levels. This study provides an early translational characterization of RDS-associated gut dysbiosis and its partial resolution following SRT, and establishes proof-of-concept for a disease-specific probiotic approach. These findings offer a new perspective on the interplay between gut microbial dynamics and the early postnatal respiratory course, and provide a basis for future investigations into microbiota-targeted strategies in neonates with RDS.

30 June 2023 in Korean Journal of Food Preservation
Verified
Journal Article
Open access
PDF file
ESEunsol Seo
Eunsol Seo
JWJang-Bin Woo
Jang-Bin Woo
MSMinYeong Seo
MinYeong Seo
JWJeongmin Woo
Jeongmin Woo
한국식품저장유통학회지(Korean Journal of Food Preservation)

14 January 2026 in The ISME Journal
Verified
Journal Article
Open access
MKMin-Geun Kang
Min-Geun Kang
DLDaniel Junpyo Lee
Daniel Junpyo Lee
AKArthur Junghun Kim
Arthur Junghun Kim
KJKi Beom Jang
Ki Beom Jang
AKAnna Kang
Anna Kang
YKYounghoon Kim
Younghoon Kim
Microplastic exposure is an emerging health risk. Host-associated plastic-degrading commensal bacteria can directly interact with microplastic particles and alter them physically and chemically, thereby potentially modulating microplastic toxicity. Despite numerous reports of plastic-degrading bacteria isolated from host intestines, how these interactions affect host physiology remains unclear. Here, we compared two polystyrene-degrading bacteria—Enterobacter hormaechei LG3 and Bacillus amyloliquefaciens SCGB1—in Caenorhabditis elegans exposed to laboratory-manufactured 1-μm polystyrene microspheres (Mi-PS). LG3-fed worms showed dose-dependent physiological impairment in response to Mi-PS, whereas SCGB1-fed worms exhibited attenuated or negligible impairment. The strains interacted with Mi-PS via distinct physiological and metabolic responses, reflected by differences in biofilm formation, particle attachment, and metabolite profiles. These strain-specific differences were confirmed to directly influence host outcomes. Under identical exposure conditions (10 mg/L, 50 h), LG3-fed worms accumulated more Mi-PS particles in the gut than SCGB1-fed worms (n = 48; mean ± SD, 3.28 ± 4.22 vs 0.63 ± 1.03 particles per worm). A transcriptome-guided validation framework provided mechanistic clues to strain-specific microplastic interactions. LG3-associated impairment coincided with the formation of oxidized Mi-PS particles, production of oxidized styrene intermediates, and microparticle-driven changes in bacterial cell properties, including activation of the lipopolysaccharide biosynthesis pathway. In contrast, SCGB1-associated attenuation was consistent with isobutyrate/isovalerate-mediated modulation of host DAF signaling. Collectively, these results link bacteria–microplastic interactions to host outcomes and offer actionable insight for assessing and mitigating microplastic-related health risks.